Longevity Stack: Epithalon + GHK-Cu + MOTS-C for Aging Research
AGING BIOLOGY
LONGEVITY RESEARCH STACK
✅ RESEARCH CHEMICAL
Research Use Only. Epithalon, GHK-Cu, and MOTS-C are sold strictly as research chemicals for in vitro and laboratory study. This article summarises published preclinical and early-phase clinical literature. It does not constitute medical advice, a treatment protocol, or a recommendation for human use.
Longevity Research Stack: Epithalon + GHK-Cu + MOTS-C for Aging Biology
The biology of ageing is not a single process — it operates through at least nine distinct hallmarks identified by López-Otín et al. (2013, Cell): telomere attrition, genomic instability, epigenetic alterations, loss of proteostasis, mitochondrial dysfunction, cellular senescence, deregulated nutrient sensing, stem cell exhaustion, and altered intercellular communication. The Longevity Research Stack targets three of these hallmarks through independent mechanisms: Epithalon addresses telomere attrition via telomerase activation; GHK-Cu targets extracellular matrix degradation, proteostasis, and oxidative stress; MOTS-C directly engages mitochondrial function and metabolic signalling via AMPK. This mechanistic non-redundancy is the scientific foundation for studying them as a combination.
Key Takeaways
- Epithalon: Ala-Glu-Asp-Gly tetrapeptide (CAS: 307297-39-8, MW: 390.35 Da) — activates telomerase (hTERT) → telomere elongation → extended replicative lifespan in cell models; Khavinson group research
- GHK-Cu: Gly-His-Lys copper complex (CAS: 89030-95-5) — activates >4,000 genes; upregulates collagen, elastin, SOD/antioxidant defence; studied in wound healing and anti-senescence models
- MOTS-C: 16-aa mitochondrial-derived peptide (CAS: 1457181-35-9, MW: ~2,174 Da) — activates AMPK → improves insulin sensitivity, exercise mimetic effects, mitochondrial biogenesis; encoded in 12S rRNA
- Three independent hallmarks of ageing addressed: telomere biology (Epithalon), ECM/oxidative stress (GHK-Cu), mitochondrial function (MOTS-C)
- All three have preclinical lifespan/healthspan data in animal models; human clinical data is limited or absent for all three in longevity context
- Epithalon extended rodent lifespan by ~14–35% in Khavinson studies (1999–2009); MOTS-C exercise mimetic data includes human metabolomics
Research-grade Epithalon, GHK-Cu, and MOTS-C from Pure Grade Labs — all supplied with full CoA documentation.
Component 1: Epithalon — Telomerase Activation and Telomere Lengthening
Epithalon (also written Epitalon; sequence: Ala-Glu-Asp-Gly; CAS: 307297-39-8; MW: 390.35 Da) is a synthetic tetrapeptide derived from Epithalamin — a polypeptide extract from the bovine pineal gland studied by Vladimir Khavinson’s group at the St. Petersburg Institute of Bioregulation and Gerontology since the 1980s. Epithalon is the defined synthetic form of the active component isolated from this extract.
The primary mechanism attributed to Epithalon in preclinical research is telomerase (hTERT) activation:
- Telomeres — the protective TTAGGG repeat sequences at chromosome ends — shorten with each cell division (the Hayflick limit mechanism). When telomeres reach a critical minimum length, cells enter senescence or apoptosis
- Telomerase (a ribonucleoprotein complex including the catalytic reverse transcriptase subunit hTERT) can extend telomeres by adding TTAGGG repeats — but its expression is repressed in most somatic cells after embryogenesis
- Epithalon administration in in vitro models has been shown to reactivate hTERT expression in somatic cells, extending telomere length and increasing the number of cell divisions before senescence (Khavinson et al., 2003, Bulletin of Experimental Biology and Medicine)
- In rodent models, Epithalon treatment showed telomere length preservation in aged animals (24-month-old mice) versus vehicle controls, correlated with reduced DNA damage markers (γH2AX foci) in lymphocytes
Lifespan extension data: Multiple Khavinson group rodent studies reported Epithalon-treated animals (SHR rats, CBA mice) lived 13–35% longer than vehicle controls. Anisimov et al. (2003) reported reduced tumour incidence alongside lifespan extension — suggesting the telomerase activation was accompanied by improved genomic stability rather than increased cancer risk (a theoretical concern with telomerase activation research).
Critical research caveat: Almost all published Epithalon research originates from the Khavinson group and has not been independently replicated in Western research institutions. This limits the evidentiary weight despite the quantity of publications. Independent replication of the telomerase activation findings is the most important gap in the Epithalon research landscape.
Component 2: GHK-Cu — Transcriptomic Reprogramming and Antioxidant Defence
GHK-Cu (glycyl-L-histidyl-L-lysine copper(II) complex; CAS: 89030-95-5) is an endogenous tripeptide-copper complex first isolated from human plasma by Pickart et al. in 1973. GHK-Cu plasma concentrations are naturally high in young individuals (~200 ng/mL at age 20) and decline significantly with age (~80 ng/mL by age 60) — a decline that has been associated with reduced wound healing capacity, increased oxidative stress, and altered collagen metabolism.
GHK-Cu’s most striking research finding is the breadth of its transcriptomic effect: a 2012 microarray analysis (Pickart and Margolina, using Broad Institute LINCS data) showed GHK-Cu modulates the expression of over 4,000 human genes — upregulating genes associated with collagen synthesis, antioxidant defence, and DNA repair while downregulating oncogenes and inflammatory pathways. Key mechanisms include:
- Collagen and ECM synthesis: Upregulation of type I and III collagen, fibronectin, and matrix metalloproteinase inhibitors (TIMPs) — promoting ECM integrity in skin, tendon, and vascular tissue. Pickart et al. (1985) demonstrated that GHK stimulates collagen synthesis in dermal fibroblast cultures at concentrations as low as 10⁻⁹ M
- Superoxide dismutase (SOD) and antioxidant activation: GHK-Cu upregulates SOD1 (copper-zinc SOD) — directly relevant as a copper-delivering agent — and other antioxidant genes. The copper chelation by GHK provides a carrier for Cu²⁺ that avoids free copper toxicity while delivering it to SOD active sites
- DNA repair induction: Upregulation of DNA repair genes (ERCC1, XPC, MLH1) has been documented in GHK-Cu-treated cell lines — suggesting a role in counteracting age-associated genomic instability
- NF-κB inhibition: Anti-inflammatory activity via NF-κB pathway suppression, reducing TNF-α and IL-6 production — complementing Epithalon’s anti-senescence profile at the inflammatory axis
Research Insight — The 4,000-Gene Paradox: The finding that a single tripeptide regulates over 4,000 genes initially seems implausible — most drugs affect a handful of pathways. The resolution lies in GHK-Cu’s mechanism of action. Rather than binding a single receptor, GHK-Cu appears to act as a transcriptional reprogramming signal through chromatin remodelling — activating or silencing broad gene networks by modifying histone acetylation and DNA methylation patterns. This places it in the category of epigenetic modulators rather than conventional receptor agonists. The practical implication is that GHK-Cu’s biological effects in longevity research are diverse by design: it is not targeting one ageing mechanism but simultaneously addressing several (ECM degradation, oxidative damage, DNA repair, inflammation) through a master regulatory signal.
Component 3: MOTS-C — Mitochondrial-Derived AMPK Activation
MOTS-C (Mitochondrial ORF of the 12S rRNA type-C; sequence: Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg; CAS: 1457181-35-9; MW: ~2,174 Da) is a 16-amino acid peptide encoded within the mitochondrial genome — specifically in the 12S ribosomal RNA gene of mitochondrial DNA. Discovered by Lee et al. in 2015 (Cell Metabolism), MOTS-C represents a class of mitochondrial-derived peptides (MDPs) that act as retrograde signals from mitochondria to the nuclear genome and systemic circulation.
MOTS-C’s primary mechanisms:
- AMPK activation: MOTS-C activates AMP-activated protein kinase (AMPK) — the master metabolic sensor that is activated when cellular energy (ATP/AMP ratio) falls. AMPK activation improves mitochondrial biogenesis, fatty acid oxidation, glucose uptake, and insulin sensitivity — the same pathway targeted by metformin (the most widely prescribed diabetes drug) and exercise
- Insulin sensitivity improvement: Lee et al. (2015) demonstrated that MOTS-C injection in diet-induced obese mice restored insulin sensitivity, reduced fasting glucose, and reduced obesity — effects comparable to exercise. MOTS-C activates the folate cycle in the folate-AICAR-AMPK pathway through metabolic reprogramming
- Exercise mimetic properties: MOTS-C plasma levels increase naturally in response to exercise in humans — it is proposed to be a mitokine (mitochondrial-derived hormone) that signals peripheral tissues to activate metabolic adaptation. Kim et al. (2018, Cell Metabolism) showed that MOTS-C administration to aged mice improved physical performance, muscle function, and metabolic health
- Longevity associations: A specific MOTS-C polymorphism (K14Q) is enriched in Japanese centenarian populations, suggesting genetic variation in MOTS-C biology is associated with exceptional human longevity — a rare finding linking a mitochondrial peptide directly to human aging outcomes
Longevity Hallmarks Addressed by the Stack
| Hallmark of Ageing (López-Otín 2013) | Epithalon | GHK-Cu | MOTS-C |
|---|---|---|---|
| Telomere attrition | ✓ Primary (hTERT) | Indirect (DNA repair) | — |
| Genomic instability | Via telomere stability | ✓ DNA repair genes | — |
| Epigenetic alterations | — | ✓ Chromatin remodelling | Via AMPK signalling |
| Mitochondrial dysfunction | — | Antioxidant (SOD1) | ✓ Primary (AMPK/biogenesis) |
| Deregulated nutrient sensing | — | — | ✓ Insulin sensitivity |
| Altered intercellular communication | — | ✓ NF-κB / inflammation | ✓ Mitokine signalling |
Pure Grade Labs supplies the full longevity research range — Epithalon, GHK-Cu, MOTS-C with research-grade purity.
Research Context — The MOTS-C Discovery Story: When Changhan Lee and colleagues at USC identified MOTS-C in 2015, it was unexpected on multiple levels. The mitochondrial genome was thought to encode only 13 proteins (all components of the respiratory chain), 22 tRNAs, and 2 rRNAs — nothing else. The discovery that a 16-amino acid ORF buried within the 12S rRNA gene was translated into a bioactive peptide and secreted into the bloodstream challenged the prevailing model of mitochondrial gene function. MOTS-C’s existence implies there may be other mitochondrial-derived peptides yet to be discovered — and that the mitochondrial genome participates in systemic metabolic communication in ways that classical biochemistry had not anticipated. MOTS-C is now the most studied mitochondrial-derived peptide, with research groups across the US, Japan, and South Korea investigating its role in ageing, metabolic disease, and exercise physiology.
Research Limitations and Evidence Quality
- Epithalon: Preclinical rodent lifespan data is promising but originates almost entirely from one research group (Khavinson) and has not been independently replicated. Human longevity data is absent. The telomerase-cancer risk question — since cancer cells use telomerase to achieve replicative immortality — is not fully resolved in Epithalon research
- GHK-Cu: Transcriptomic data is compelling but mechanism of transcriptional regulation (how a tripeptide modulates 4,000 genes) remains incompletely characterised. Most wound healing and collagen data is from in vitro models or small observational studies in dermatology. No large RCT for longevity-specific endpoints
- MOTS-C: The most recently discovered of the three; research literature is growing rapidly but relatively thin compared to peptides with 30+ years of study. Mouse studies are replicated across multiple groups; human data is primarily observational (plasma MOTS-C levels in exercise and centenarian cohorts)
- Combination data: No published co-administration trial for this specific three-compound combination exists. Stack design represents a mechanistically coherent research hypothesis awaiting formal preclinical testing
Frequently Asked Questions
What is the Longevity Research Stack designed to study?
The stack is designed to address multiple independent hallmarks of ageing simultaneously: telomere attrition (Epithalon/hTERT), ECM degradation, oxidative stress, and DNA repair (GHK-Cu), and mitochondrial dysfunction and metabolic deregulation (MOTS-C/AMPK). The non-redundancy of the three mechanisms is the research rationale.
Does Epithalon activate telomerase and could this increase cancer risk?
Epithalon has been shown to activate hTERT in in vitro models. The cancer risk question is theoretically relevant since telomerase activation is a feature of most cancer cells. Notably, the Khavinson rodent studies reported reduced tumour incidence alongside lifespan extension — suggesting the effect may be context-dependent (restoring telomerase in senescent normal cells vs constitutively active telomerase in cancer). Independent replication of both the telomerase activation and the tumour incidence data is needed before firm conclusions can be drawn.
What does MOTS-C do in exercise research?
MOTS-C levels in human plasma rise in response to exercise. In aged mice, MOTS-C injection restored exercise capacity, muscle function, and metabolic parameters comparable to a young active phenotype. MOTS-C activates AMPK through the folate cycle pathway (folate → AICAR → AMPK), improving mitochondrial biogenesis and fatty acid oxidation — mechanisms that parallel exercise-induced metabolic adaptation, hence its classification as an exercise mimetic peptide.
How does GHK-Cu regulate 4,000 genes?
GHK-Cu appears to act as an epigenetic reprogramming signal — modifying histone acetylation patterns and DNA methylation through chromatin remodelling mechanisms rather than binding a single receptor. This broad transcriptional effect has been characterised using LINCS database microarray analysis across multiple cell lines. The mechanism for how a single tripeptide-copper complex achieves this breadth of gene regulation is not yet fully characterised at the molecular level.
Summary
The Longevity Research Stack is organised around the López-Otín hallmarks of ageing framework — using each compound to address a distinct biological axis. Epithalon targets the telomere clock through hTERT activation with rodent lifespan data that, while requiring independent replication, represents one of the most direct interventions in the telomere attrition hallmark studied. GHK-Cu’s 4,000-gene transcriptomic reach addresses ECM, antioxidant, and DNA repair biology simultaneously through apparent epigenetic reprogramming. MOTS-C completes the stack by engaging the mitochondrial function and nutrient sensing hallmarks through AMPK — the master metabolic regulator whose activity is strongly associated with healthspan in both model organisms and human longevity cohorts. The combination represents an evidence-grounded research hypothesis across three of ageing’s most studied biological axes.
Source Epithalon, GHK-Cu, and MOTS-C research-grade from Pure Grade Labs.
References
- Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003;135(6):590–592. PMID: 12937682
- Anisimov VN, Khavinson VKh, Provinciali M, et al. Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Int J Cancer. 2002;101(1):7–10. PMID: 12360209
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. PMID: 26065014
- Pickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nat New Biol. 1973;243(124):85–87. PMID: 4512889
- Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443–454. PMID: 25738459
- Kim SJ, Xiao J, Wan J, et al. Mitochondrially derived peptides as novel regulators of metabolism. J Physiol. 2017;595(21):6613–6621. PMID: 28771787
- López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194–1217. PMID: 23746838
Disclaimer: This article is published for educational and research purposes only. Epithalon, GHK-Cu, and MOTS-C are sold by Pure Grade Labs strictly as research chemicals, not for human consumption or therapeutic use. No claims are made regarding life extension, anti-aging effects, or disease treatment in humans. All research use must comply with applicable institutional and regulatory requirements.